Boston Scientific (BSX) has taken its new investor relations VP from Abiomed (ABMD), the company known for the world’s smallest heart pump and AbioCor. Susan Lisa has served as the senior director of investor relations and corporate development at Abiomed since 2012, according to her LinkedIn profile. She will begin her role as VP of investor relations at Boston Scientific Dec. 2.
According to the press release from Boston Scientific:
Prior to joining Abiomed, Lisa held several roles of increasing responsibility within the Equity division at Bank of America Merrill Lynch, including head of Specialist Sales. Additionally, Lisa spent four years as an equity research analyst covering medical technology, both at Merrill Lynch and Cowen & Co, and began her career at JP Morgan Chase & Co
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Michael Campbell is the current VP of investor relations at BSX. He’s been with the company more than a decade.
On Oct. 24, the medical device company announced a restructuring plan that included naming a new CFO who will begin Jan. 1, and potentially shedding 1,500 jobs.
Follow MedCity News on Facebook and Twitter for more updates.
CORRECTION: This appointment is not part of the October company restructuring plan.
